Alderson P , Schierhout G , Roberts I , Bunn F.2000. Colloids versus crystalloids for fluid resuscitation in critically ill patients . Cochrane Database Syst Rev2: CD000567–CD000567 .
2.
Allison KP , Gosling P , Jones S , Pallister I , Porter KM . 1999. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation . J Trauma47: 1114–1121 .
3.
Balogh Z , McKinley BA , Cocanour CS et al. 2003. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome . Arch Surg138: 637–642 .
4.
Baron JF . 1999. Blood substitutes. Haemoglobin therapeutics in clinical practice . Crit Care3: R99–102 .
5.
Battle J , del Rio F , Lopez Fernandez MF et al. 1985. Effect of dextran on factor VIII/von Willebrand factor, structure and function . Thromb Haemost54: 697–699 .
6.
Bunn F , Roberts I , Tasker R , Akpa E.2002. Hypertonic versus isotonic crystalloid for fluid resuscitation in critically ill patients . Cochrane Database Syst Rev1: CD002045-CD002045 .
7.
Bunn F , Alderson P , Hawkins V.2004. Colloid solutions for fluid resuscitation . Cochrane Database Syst Rev1: CD001319–CD001319
8.
Choi PT , Yip G , Quinonez LG , Cook DJ . 1999. Crystalloids vs. colloids in fluid resuscitation: a systematic review . Crit Care Med27: 200–210 .
9.
Cooper DJ , Myles PS , McDermott FT et al. 2004. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial . JAMA291: 1350–1357 .
10.
Cullen MJ , Singer M.1990. Severe anaphylactoid reaction to hydroxyethyl starch . Anaesthesia45: 1041–1042 .
11.
de Jonge E , Levi M.2001. Effects of different plasma substitutes on blood coagulation: a comparative review . Crit Care Med29: 1261–1267 .
12.
Deitch EA , Shi HP , Feketeova E , Hauser CJ , Xu DZ . 2003. Hypertonic saline resuscitation limits neutrophil activation after trauma-hemorrhagic shock . Shock19: 328–333 .
13.
Dorman T , Breslow MJ . 1994. Altered immune function after trauma and hemorrhage: what does it all mean?Crit Care Med22: 1069–1070 .
Finfer S , Bellomo R , Boyce N , French J , Myburgh J , Norton R.2004. A comparison of albumin and saline for fluid resuscitation in the intensive care unit . N Engl J Med350: 2247–2256 .
Gan TJ , Bennett-Guerrero E , Phillips-Bute B et al. 1999. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group . Anesth Analg88: 992–998 .
18.
Greaves I , Porter KM , Revell MP .2002. Fluid resuscitation in pre-hospital trauma care: a consensus view . J R Coll Surg Edinb47(2): 451–457 .
19.
Grocott MP , Hamilton MA . 2002. Resuscitation fluids . Vox Sang82(1): 1–8 .
20.
Grocott MPW , Mythen MG . 1999. Fluid therapy. In Goldhill DR and Strunin , eds, Bailliere's clinical anaesthesiology, 13(3). Harcourt Publishers Ltd , 363–381.
21.
Haljamae H , Dahlqvist M , Walentin F.1997. Artificial colloids in clinical practice: pros and cons. In Haljamäe H , eds, Bailliere's clinical anaesthesiology, 11. Harcourt Publishers Ltd , 49–79.
22.
Hebert PC , Wells G , Blajchman MA et al. 1999. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group . N Engl J Med340: 409–417 .
23.
Hedin H , Richter W , Ring J.1976. Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies . Int Arch Allergy Appl Immunol52: 145–159 .
24.
Karoutsos S , Nathan N , Lahrimi A , Grouille D , Feiss P , Cox DJ . 1999. Thrombelastogram reveals hypercoagu-lability after administration of gelatin solution . Br J Anaesth82: 175–177 .
25.
Kramer GC . 2003. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care . J Trauma54 (5 Suppl): S89–S99 .
26.
Lamke LO , Liljedahl SO . 1976. Plasma volume changes after infusion of various plasma expanders . Resuscitation5: 93–102 .
27.
Laubenthal H , Messmer K.1992. Allergic reactions to dextrans. In Baron FJ ed. Plasma volume expansion. Arnette Blackwell .
28.
Laxenaire MC , Charpentier C , Feldman L.1994. [Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study] . Ann Fr Anesth Reanim13: 301–310 .
29.
Lorenz W , Doenicke A , Messmer K et al. 1976. Histamine release in human subjects by modified gelatin (Haemaccel) and dextran: an explanation for anaphylactoid reactions observed under clinical conditions?Br J Anaesth48: 151–165 .
30.
Malone DL , Dunne J , Tracy JK , Putnam AT , Scalea TM , Napolitano LM . 2003. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma . J Trauma54: 898–905 .
31.
Mardel SN , Saunders FM , Allen H et al. 1998. Reduced quality of clot formation with gelatin-based plasma substitutes . Br J Anaesth80: 204–207 .
32.
Moore EE , Johnson JL , Cheng AM , Masuno T , Banerjee A.2005. Insights from studies of blood substitutes in trauma . Shock24: 197–205 .
33.
Pascual JL , Khwaja KA , Chaudhury P , Christou NV . 2003. Hypertonic saline and the microcirculation . J Trauma54(5 Suppl): S133–S140 .
34.
Ramsay G.1988. Intravenous volume replacement: indications and choices . Br Med J (Clin Res Ed)296: 1422–1423 .
35.
Ring J , Messmer K.1977. Incidence and severity of anaphylactoid reactions to colloid volume substitutes . Lancet1: 466–469 .
36.
Rizoli SB , Kapus A , Fan J , Li YH , Marshall JC , Rotstein OD . 1998. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock . J Immunol161: 6288–6296 .
37.
Rizoli SB . 2003. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate . J Trauma54(5 Suppl): S82–S88 .
38.
Roberts I , Alderson P , Bunn F , Chinnock P , Ker K , Schierhout G.2004. Colloids versus crystalloids for fluid resuscitation in critically ill patients . Cochrane Database Syst Rev4: CD000567-CD000567 .
39.
Ruttmann TG , James MF , Aronson I.1998. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation . Br J Anaesth80: 612–616 .
40.
Saddler JM , Horsey PJ . 1987. The new generation gelatins. A review of their history, manufacture and properties . Anaesthesia42(9): 998–1004 .
41.
Salmon JB , Mythen MG . 1993. Pharmacology and physiology of colloids . Blood Rev7: 114–120 .
42.
Schierhout G , Roberts I.1998. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials . Br Med J316: 961–964 .
43.
Shi HP , Deitch EA , Da Xu Z , Lu Q , Hauser CJ . 2002. Hypertonic saline improves intestinal mucosa barrier function and lung injury after trauma-hemorrhagic shock . Shock17: 496–501 .
44.
Sloan EP , Koenigsberg M , Gens D et al. 1999. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial . JAMA282: 1857–1864 .
Tabuchi N , de Haan J , Gallandat Huet RC , Boonstra PW , van Oeveren W.1995. Gelatin use impairs platelet adhesion during cardiac surgery . Thromb Haemost74: 1447–1451 .
47.
Treib J , Haass A , Pindur G , Grauer MT , Wenzel E , Schimrigk K.1996a. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation . Transfusion36: 450–455 .
48.
Treib J , Haass A , Pindur G et al. 1996b. Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration . Haemostasis26: 210–213 .
49.
Treib J , Haass A , Pindur G.1997. Coagulation disorders caused by hydroxyethyl starch . Thromb Haemost78: 974–983 .
50.
Velanovich V.1989. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality . Surgery105: 65–71 .
51.
Wade CE , Grady JJ , Kramer GC . 2003. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma . J Trauma54(5 Suppl): S144–S148 .
52.
Watenpaugh DE , Gaffney FA . 1998. Measurement of net whole-body transcapillary fluid transport and effective vascular compliance in humans . J Trauma45: 1062–1068 .
53.
Webb AR , Moss RF , Tighe D et al. 1992. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis . Intensive Care Med18: 348–355 .
54.
Wilkes NJ , Woolf R , Mutch M et al. 2001. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients . Anesth Analg93: 811–816 .